First Time Loading...

Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 72.65 USD -0.27%
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one BSX stock under the Base Case scenario is 71.28 USD. Compared to the current market price of 72.65 USD, Boston Scientific Corp is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSX Relative Value
Base Case
71.28 USD
Overvaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.3
P/S
P/S
Price to Sales
7.3
vs History
0
vs Industry
19
Median 3Y
5.5
Median 5Y
5.4
Industry
2.4
Forward
6.8
More Details
60.5
P/E
P/E
Price to Earnings
60.5
vs History
50
vs Industry
7
Median 3Y
79.9
Median 5Y
60.5
Industry
23.4
Forward
32
More Details
42.5
P/OCF
P/OCF
Price to OCF
42.5
vs History
31
vs Industry
8
Median 3Y
37.4
Median 5Y
37.3
Industry
15.5
More Details
68
P/FCFE
P/FCFE
Price to FCFE
68
vs History
28
vs Industry
9
Median 3Y
62.6
Median 5Y
54.6
Industry
23.2
More Details
5.5
P/B
P/B
Price to Book Value
5.5
vs History
12
vs Industry
15
Median 3Y
3.9
Median 5Y
3.9
Industry
2.3
More Details
7.8
EV/S
EV/S
Enterprise Value to Sales
7.8
vs History
0
vs Industry
16
Median 3Y
6.1
Median 5Y
6.1
Industry
2.5
Forward
7.3
More Details
11.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.2
vs History
0
vs Industry
20
Median 3Y
8.9
Median 5Y
8.9
Industry
5.3
More Details
30.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.9
vs History
38
vs Industry
9
Median 3Y
24.7
Median 5Y
28.3
Industry
12.6
Forward
25.3
More Details
45.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.6
vs History
23
vs Industry
8
Median 3Y
37.3
Median 5Y
37.8
Industry
17.2
Forward
27.5
More Details
45.8
EV/OCF
EV/OCF
Enterprise Value to OCF
45.8
vs History
34
vs Industry
8
Median 3Y
41.1
Median 5Y
42.1
Industry
15.3
More Details
63.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
63.9
vs History
47
vs Industry
7
Median 3Y
57.8
Median 5Y
63.4
Industry
19.8
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
0
vs Industry
25
Median 3Y
2.4
Median 5Y
2.4
Industry
2
More Details

Multiples Across Competitors

BSX Competitors Multiples
Boston Scientific Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Boston Scientific Corp
NYSE:BSX
107B USD 7.3 60.5 30.9 45.6
US
Abbott Laboratories
NYSE:ABT
183.3B USD 4.5 32.5 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.2 55.9 70
US
Stryker Corp
NYSE:SYK
124.2B USD 5.9 36.9 24 29.6
IE
Medtronic PLC
NYSE:MDT
108.5B USD 3.4 25.8 13.7 19.4
US
Becton Dickinson and Co
NYSE:BDX
68.6B USD 3.5 56 18.8 39.7
DE
Siemens Healthineers AG
XETRA:SHL
58.6B EUR 2.7 38.6 18.5 31.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
378.7B CNY 11 33.4 29.1 29.1
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.3 28.5
US
Dexcom Inc
NASDAQ:DXCM
51.3B USD 13.5 80.5 59.9 78
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.4B USD 10.6 45.6 32.4 35.8

See Also

Summary
BSX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BSX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BSX stock valuation using valuation multiples.
Wall Street Estimates
BSX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BSX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.